Maximum historical sales of the company reached during my tenure, as well as historical maximum monthly sales average.International negotiation of prices, volumes and contracts with world leading companies in genomics, personalized medicine and pharmacogenomics.Creation of a professional and responsible team focused on the execution of activities and oriented to results and metrics. Responsible for the supervision of the area of biomedicine, biodata, communication, marketing, sales, accounting and operations.Commercial growth with the international expansion of clients in Guatemala and El Salvador, adding as key partners in the region the specialized oncology centers. I also managed to triple the number of affiliates, signing contracts with more than 100 medical clinics, hospitals and laboratories within the country. At least one regional partner has been consolidated in each state of the Mexican Republic for the offer of GENETEST tests.I developed the Genetest Academy area, an area focused on research and scientific dissemination around personalized medicine, genetics and the company's products. I was involved in the definition of program goals, the development of course content, supervision of the study plan and its dissemination to attract doctors and scientists. Promote the Creation of the ELSIE magazine, a journal of dissemination and scientific research, with the participation of different cancer foundations.I have cultivated inter-institutional relationships many Universities of Mexico,developing scientific talent and linking the private sector and scientific education in Mexico.Develop all the necessary support for the supply of genetic products in the country, reception and international shipments of saliva, biopsy and blood samples, complying with the country's Health authority, COFEPRIS.Develop a policy for the protection of personal data and privacy of the genetic information of the clients to protect them and protect the company.

Consulting firm specialized in statistics focused on health for decision making in the public sector and development of government programs.Develop the feasibility analysis of risk transfer from the public to the private sector in insurance, calculating the utility for a consortium of insurers to be able to take charge of a government trust, be able to generate profits, create savings to the public sector and make transparent and efficient the social programs.Develop the demographic projections for Mexico City 2015-2030 to calculate health sector expenditures and projections for chronic degenerative diseases.Carry out the cost scheme of public health policies Mexico City 2015-2024 and the calculation of costs for the public sector associated with heart disease and diabetes.

Life and financial risk insurer.Pricing of new products, calculation of profits and risk premiums for products according to market demand.Development of operational and financial rules for new insurance.Negotiation with Assurant International for resistance and risk margins for new insurance products.Development of risk acceptance criteria for new business units.Accompaniment to the commercial area in prospecting and closing key accounts.

Mexican Association of Insurance Institutions.Life Insurance Manuals Update for AMISProjections and rates of life insurance for mothers head of householdData analysis for representative statistics of the Life Insurance Sector for Mexic